Health
Results: 529-540 of 8097

Almirall Announces “LumiNE”, a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema

First Patients in the UK Receive Doses of Blue Earth Therapeutics' Investigational Radiopharmaceutical Therapy Lutetium (177Lu) rhPSMA-10.1 Injection for Metastatic Castrate Resistant Prostate Cancer

TetraScience Appoints Matt Studney as Chief Customer Officer, Signaling Industry Shift Toward Platform-Based Scientific AI

Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease

Affidea acquires a majority stake in LabPoint from Lindenhofgruppe, strengthening its diagnostics and laboratory medicine capabilities






